Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-24 · accession 0001209191-23-005037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-26 | 2023-01-24+ | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $21.85 | -1,097 | 34.8K | -3% | -$24.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-24 | S | D | 905 | $21.90 | 35,028 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-25 | S | D | 192 | $21.63 | 34,836 | D | — | — |